Covid-19 vaccine (0-1-6 schedule)
Sponsors
China National Biotec Group Company Limited
Conditions
COVID-19 Pneumonia
Phase 4
Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes
NCT05104437
Start: 2021-11-30End: 2022-12-31Target: 1440Updated: 2021-11-03
Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes
NCT05104333
Start: 2021-11-30End: 2022-12-31Target: 1440Updated: 2021-11-03